Osteoarthritis News and Research

Latest Osteoarthritis News and Research

COPD patients also experience significant amounts of chronic pain, researchers say

Chronic obstructive pulmonary disease is primarily associated with the respiratory symptoms that are its hallmark, but in fact, patients who struggle with the disease also experience significant amounts of chronic pain.

22 May 2013

Joint replacement surgery might be avoidable in the future, suggest scientists

Scientists at Johns Hopkins have turned their view of osteoarthritis inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, they now have evidence that the bone underneath the cartilage is also a key player and exacerbates the damage.

20 May 2013

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that the European Patent Office has issued a notice of Intention to Grant a European Patent that provides protection for the Company's PENNSAID 2% product.

9 May 2013

POZEN announces revenue of $1.4 million for first quarter 2013

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the first quarter ended March 31, 2013.

8 May 2013

EPSRC-funded study explores feasibility of using natural fibres for cartilage repair

Over 20 million people in Europe suffer from osteoarthritis which can lead to extensive damage to the knee and hip cartilage. Stem cells offer a promising way forward but a key challenge has been to design a 'smart material' that is biologically effective for cartilage tissue regeneration. Now researchers have identified a blend of naturally occurring fibres such as cellulose and silk that makes progress towards affordable and effective cell-based therapy for cartilage repair a step closer

8 May 2013

Nuvo Research intends to proceed with its proposed share consolidation

Nuvo Research Inc. (the "Company" or "Nuvo"), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it will proceed with its proposed share consolidation (the "Consolidation"), as approved by the shareholders of Nuvo at the annual and special meeting held on May 15, 2012, on the basis of 65 pre-Consolidation common shares for one (1) post-Consolidation common share.

7 May 2013

New joint lubricant brings longer lasting relief to osteoarthritis sufferers

A team of researchers led by a Boston University Biomedical Engineer has developed a new joint lubricant that could bring longer lasting relief to millions of osteoarthritis sufferers.

3 May 2013

Upcoming symposium to offer highlights of 150-year history of Hospital for Special Surgery

An upcoming symposium will offer highlights of the 150-year history of Hospital for Special Surgery and at the same time provide a fascinating look at the evolution of medicine from the "Dark Ages" of the Civil War period to modern medicine as we know it today.

29 Apr 2013

Ampio completes patient enrollment in dose-escalation run-in study of Ampion for treatment of knee osteoarthritis

Ampio Pharmaceuticals, Inc. today announced the completion of patient enrollment in a dose-escalation run-in study to a Phase III pivotal trial evaluating Ampion in the treatment of moderate to severe osteoarthritis of the knee.

26 Apr 2013

Biological imaging technologies create a new way to learn about cells

Researchers have married two biological imaging technologies, creating a new way to learn how good cells go bad. "Let's say you have a large population of cells," said Corey Neu, an assistant professor in Purdue University's Weldon School of Biomedical Engineering.

26 Apr 2013

Nuvo Research reaches another milestone with the launch of Pliaglis in Europe

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and Galderma Pharma, S.A., today announced the European launch of Pliaglis (lidocaine and tetracaine) Cream 7%/7%.

23 Apr 2013

Eating mushrooms can help increase, maintain vitamin D levels, find BUSM researchers

Researchers from Boston University School of Medicine have discovered that eating mushrooms containing Vitamin D2 can be as effective at increasing and maintaining vitamin D levels (25-hydroxyvitamin D) as taking supplemental vitamin D2 or vitamin D3.

23 Apr 2013

$Study shows 30.4% of hip fracture patients in India died within one year$

Study shows 30.4% of hip fracture patients in India died within one year

In various studies across different countries the reported one year mortality risks after hip fracture can vary anywhere from 5 to 50 %. In India, however, there has been little research on the risk of mortality and functional impairment following hip fracture.

23 Apr 2013

$Belgian investigators present study results of hip fracture in older patients at ESCEO13-IOF$

Belgian investigators present study results of hip fracture in older patients at ESCEO13-IOF

Although hip fractures in older patients are known to be a major cause of long term disability and increased risk of death, less is known about the relationship between surgical delay after hip fracture and mortality risk.

23 Apr 2013

Study indentifies unmet medical need for treatment of patients with chronic pain and dysphagia

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the completion of a research study, conducted with an independent market research firm, that identified a significant unmet medical need for improved treatments for patients with chronic pain and dysphagia/odynophagia. In clinical practice, dysphagia is most often defined as difficulty in swallowing and odynophagia is defined as pain upon swallowing.

22 Apr 2013

Investigator honored for advancing osteoporosis research and advocacy worldwide

Professor Socrates Papapoulos, a long standing member of the IOF Board and leading researcher at the Leiden University Medical Center, has been named the recipient of the prestigious Pierre Delmas Award.

22 Apr 2013

Researcher discovers additional mechanical properties of articular cartilage result in osteoarthritis

A researcher at The Feinstein Institute for Medical Research has discovered additional mechanical properties of articular cartilage, a protective cartilage on the ends of bones that wears down over time, resulting in the development of osteoarthritis.

20 Apr 2013

IOF honors Spanish researcher for contributions to clinical research in the field of osteoporosis

The IOF Medal of Achievement has been presented today to Professor Adolfo Diez-Perez, MD, PhD, Head Emeritus of the Department of Internal Medicine, Hospital del Mar, Director of the Bone and Joint Research Unit at the Municipal Institute of Medical Research and Professor of Medicine at the Autonomous University of Barcelona.

20 Apr 2013

UCSF Professor receives Olof Johnell Science Award for achievements in metabolic bone disease

Harry Genant, Professor Emeritus of the University of California San Francisco, has been named the winner of the International Osteoporosis Foundation's (IOF) first Olof Johnell Science Award.

19 Apr 2013

Knee brace can improve symptoms, function for people with knee osteoarthritis

Wearing a knee brace has been shown to "significantly improve the pain and symptoms" of a type of osteoarthritis affecting the kneecap, according to a new study.

From The University of Manchester 19 Apr 2013

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

COPD patients also experience significant amounts of chronic pain, researchers say

Joint replacement surgery might be avoidable in the future, suggest scientists

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

POZEN announces revenue of $1.4 million for first quarter 2013

EPSRC-funded study explores feasibility of using natural fibres for cartilage repair

Nuvo Research intends to proceed with its proposed share consolidation

New joint lubricant brings longer lasting relief to osteoarthritis sufferers

Upcoming symposium to offer highlights of 150-year history of Hospital for Special Surgery

Ampio completes patient enrollment in dose-escalation run-in study of Ampion for treatment of knee osteoarthritis

Biological imaging technologies create a new way to learn about cells

Nuvo Research reaches another milestone with the launch of Pliaglis in Europe

Eating mushrooms can help increase, maintain vitamin D levels, find BUSM researchers

Study shows 30.4% of hip fracture patients in India died within one year

Belgian investigators present study results of hip fracture in older patients at ESCEO13-IOF

Study indentifies unmet medical need for treatment of patients with chronic pain and dysphagia

Investigator honored for advancing osteoporosis research and advocacy worldwide

Researcher discovers additional mechanical properties of articular cartilage result in osteoarthritis

IOF honors Spanish researcher for contributions to clinical research in the field of osteoporosis

UCSF Professor receives Olof Johnell Science Award for achievements in metabolic bone disease

Knee brace can improve symptoms, function for people with knee osteoarthritis

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in